These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 19120899
21. [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study]. Li W, Wang X, Cheng G. Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):258-60. PubMed ID: 10920977 [Abstract] [Full Text] [Related]
22. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer. Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R. Clin Cancer Res; 2005 Jan 01; 11(1):180-5. PubMed ID: 15671544 [Abstract] [Full Text] [Related]
23. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH). Guidi E, Uboldi C, Ferretti L. Cytogenet Genome Res; 2008 Jan 01; 120(1-2):173-7. PubMed ID: 18467844 [Abstract] [Full Text] [Related]
24. Fragile histidine triad gene and skin cancer. Zanesi N, Croce CM. Eur J Dermatol; 2001 Jan 01; 11(5):401-4. PubMed ID: 11525944 [Abstract] [Full Text] [Related]
25. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas. Goldberg M, Rummelt C, Laerm A, Helmbold P, Holbach LM, Ballhausen WG. Br J Dermatol; 2006 Dec 01; 155(6):1154-8. PubMed ID: 17107382 [Abstract] [Full Text] [Related]
26. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites. Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y. Mol Cancer Res; 2005 Mar 01; 3(3):130-8. PubMed ID: 15798093 [Abstract] [Full Text] [Related]
27. Down-regulation of fragile histidine triad expression in prostate carcinoma. Fouts RL, Sandusky GE, Zhang S, Eckert GJ, Koch MO, Ulbright TM, Eble JN, Cheng L. Cancer; 2003 Mar 15; 97(6):1447-52. PubMed ID: 12627509 [Abstract] [Full Text] [Related]
28. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell]. Wang Y, Zhou Q, Zhang S, Yang H, Cheng N, Li L, Wu Z, Liu L. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun 15; 18(3):178-82. PubMed ID: 11402444 [Abstract] [Full Text] [Related]
29. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions. Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M. Mutat Res; 2006 Jul 25; 599(1-2):45-57. PubMed ID: 16698048 [Abstract] [Full Text] [Related]
30. Expression of FHIT in esophageal epithelium and carcinoma: reference to drinking, smoking and multicentric carcinogenesis. Morita M, Oyama T, Nakata S, Ono K, Sugaya M, Uramoto H, Yoshimatsu T, Hanagiri T, Sugio K, Yasumoto K. Anticancer Res; 2006 Jul 25; 26(3B):2243-8. PubMed ID: 16821595 [Abstract] [Full Text] [Related]
31. Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer. Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP. Cancer Epidemiol Biomarkers Prev; 2006 Nov 25; 15(11):2232-8. PubMed ID: 17119051 [Abstract] [Full Text] [Related]
34. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history. Shimada Y, Sato F, Watanabe G, Yamasaki S, Kato M, Maeda M, Imamura M. Cancer; 2000 Jul 01; 89(1):5-11. PubMed ID: 10896994 [Abstract] [Full Text] [Related]
35. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation. Hussain A, Gutiérrez MI, Timson G, Siraj AK, Deambrogi C, Al-Rasheed M, Gaidano G, Magrath I, Bhatia K. Genes Chromosomes Cancer; 2004 Dec 01; 41(4):321-9. PubMed ID: 15384174 [Abstract] [Full Text] [Related]
36. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells. Yu GR, Qin WW, Li JP, Hua W, Meng YL, Chen R, Yan B, Wang L, Zhang X, Jia LT, Zhao J, Zhang R, Yang AG. Biosci Rep; 2012 Jun 01; 32(3):271-9. PubMed ID: 21679157 [Abstract] [Full Text] [Related]
37. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line. Song X, Tian Z, Wang S, Peng Z, Feng J. Cancer Invest; 2010 Dec 01; 28(10):1019-23. PubMed ID: 20690795 [Abstract] [Full Text] [Related]
38. [Loss of exons of FHIT gene and FHIT protein expression in Yunnan tin miners with lung cancer]. Ruan YH, Gao Q, Zhang L, Hua HR, Cheng JL, Jin KW. Ai Zheng; 2007 Jun 01; 26(6):607-12. PubMed ID: 17562266 [Abstract] [Full Text] [Related]
39. [Impact of fragile histidine triad gene transfection on the proliferation and apoptosis of human colorectal cancer cell]. Cao J, Liang LY, Yang P, Qian YJ, Wang H, Sun Z, Li WL, Tan MH. Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep 01; 13(9):691-4. PubMed ID: 20878579 [Abstract] [Full Text] [Related]
40. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles. Uboldi C, Guidi E, Roperto S, Russo V, Roperto F, Di Meo GP, Iannuzzi L, Floriot S, Boussaha M, Eggen A, Ferretti L. BMC Genomics; 2006 May 23; 7():123. PubMed ID: 16719907 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]